Clinical Trial Update: Exhaled NO as a Biomarker of Gestational OSA and Persistence Postpartum

View source ↗

Summary

A completed clinical trial evaluating exhaled nitric oxide as a biomarker for gestational obstructive sleep apnea and its persistence postpartum.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Pregnancy, OSA | Status: COMPLETED